Isixhobo sokujonga i-COVID-19
I-antibody engathathi hlangothi ngokuchasene ne-SARS-CoV-2 inokumelana nosulelo lwabantu lwe-SARS-CoV-2.
Ke ngoko, ukufunyaniswa kwe-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-anti-i-neuthematics kwi-SARS-CoV-2, kunokubaluleka okubalulekileyo kwezonyango kwizigulana ezinosulelo lwe-convalescent okanye kugonyo lwe-SARS-CoV-2.
IKhiti yoVavanyo lwe-SARS-CoV-2 ye-Neutralizing Antibody yeyokuchongwa okusemgangathweni kwee-antibodies ze-SARS-CoV-2 kwiserum yomntu, iplasma okanye isampulu yegazi lonke. Ikhithi yovavanyo yenzelwe ukusetyenziswa ngaphandle komzimba kuphela (ukusetyenziswa kwe-in vitro diagnostic) ukuze isetyenziswe kubuchwephesha kwaye ayifanelanga ukuba isetyenziselwe ukufumanisa usulelo oluqatha lwe-SARS-CoV-2.
Umhlalutyi
Ikhithi yoVavanyo
Imveliso
Indlela
Uhlobo lomzekelo
Umthamo wesampuli
Ixesha lovavanyo
Ubungakanani bepakethi
Ugcino
I-SARS-CoV-2 Ikhithi yoVavanyo lwe-Antibody engathathi hlangothi
I-Fluorescence Immunochromatography
ISerum, iplasma okanye isampulu yegazi elipheleleyo
25µl
Imizuzu eli-10
25 iipcs / ibhokisi; 50 iipcs / ibhokisi
4℃~30℃